think it’s being overlooked that monepatel is a potential solution to a range of neurodegenrative disorders not just MND. Pathway for Alzheimers is impacted via mTor pathway as supported below. Massive opportunities - PAA could be a game changer!
Slide 13
Souce: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6335350/
Source: https://www.mdpi.com/1422-0067/20/3/728
Most excited about the Neurodegenerative preclinical results. Monepantel is a selective mTor inhibitor and reduces autophagy. This is the main driver of Parkinson’s and Alzheimers.
think it’s being overlooked that monepatel is a potential...
Add NUZ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.0¢ |
Change
0.005(2.70%) |
Mkt cap ! $93.42M | |||
| Open | High | Low | Value | Volume |
| 19.0¢ | 19.5¢ | 19.0¢ | $60.84K | 317.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 120380 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.5¢ | 22618 | 3 |
View Market Depth
| Last trade - 16.10pm 19/11/2024 (20 minute delay) ? |
| NUZ (ASX) Chart |